These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8978258)
1. Adverse events associated with mefloquine. Risk-benefit ratio must be taken into account. Dollow S BMJ; 1996 Dec; 313(7071):1553; author reply 1554. PubMed ID: 8978258 [No Abstract] [Full Text] [Related]
2. Adverse events associated with mefloquine. Study in returned travellers confirms authors' findings. Corbett EL; Doherty JP; Behrens RH BMJ; 1996 Dec; 313(7071):1552. PubMed ID: 8978255 [No Abstract] [Full Text] [Related]
3. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. Barrett PJ; Emmins PD; Clarke PD; Bradley DJ BMJ; 1996 Aug; 313(7056):525-8. PubMed ID: 8789977 [TBL] [Abstract][Full Text] [Related]
4. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers. Petersen E; Ronne T; Ronn A; Bygbjerg I; Larsen SO J Travel Med; 2000; 7(2):79-84. PubMed ID: 10759574 [TBL] [Abstract][Full Text] [Related]
5. Drugs for preventing malaria in travellers. Jacquerioz FA; Croft AM Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371 [TBL] [Abstract][Full Text] [Related]
6. Science commentary: protection against malaria. Berger A BMJ; 1998 Nov; 317(7171):1508. PubMed ID: 9831585 [No Abstract] [Full Text] [Related]
7. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists]. Carme B; Péguet C; Nevez G Bull Soc Pathol Exot; 1997; 90(4):273-6. PubMed ID: 9479468 [TBL] [Abstract][Full Text] [Related]
8. Adverse events associated with mefloquine. Women may be more susceptible to adverse events. Phillips M BMJ; 1996 Dec; 313(7071):1552-3. PubMed ID: 8978256 [No Abstract] [Full Text] [Related]
11. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997 [TBL] [Abstract][Full Text] [Related]
12. Neuro-psychiatric effects of antimalarials. van Riemsdijk MM; van der Klauw MM; van Heest JA; Reedeker FR; Ligthelm RJ; Herings RM; Stricker BH Eur J Clin Pharmacol; 1997; 52(1):1-6. PubMed ID: 9143859 [TBL] [Abstract][Full Text] [Related]
13. Mefloquine has more adverse effects than other drugs for malaria prophylaxis. Eaton L BMJ; 2009 Oct; 339():b4167. PubMed ID: 19825970 [No Abstract] [Full Text] [Related]
14. Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case-control study in the Netherlands. van Riemsdijk MM; Sturkenboom MC; Pepplinkhuizen L; Stricker BH J Clin Psychiatry; 2005 Feb; 66(2):199-204. PubMed ID: 15705005 [TBL] [Abstract][Full Text] [Related]
15. Methodological concerns regarding the relation between mefloquine and serious psychiatric events in females. Tepper ML; Strauss BA J Clin Psychiatry; 2006 Jan; 67(1):164; author reply 164-5. PubMed ID: 16426106 [No Abstract] [Full Text] [Related]
16. Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation. Davis TM Ann Pharmacother; 1998 Oct; 32(10):1104-6. PubMed ID: 9793605 [No Abstract] [Full Text] [Related]
17. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K; Scott L Drugs; 2003; 63(6):597-623. PubMed ID: 12656656 [TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric events and travel: do antimalarials play a role? Schlagenhauf P; Steffen R J Travel Med; 2000; 7(5):225-6. PubMed ID: 11231204 [No Abstract] [Full Text] [Related]